Research Institution Gap Funding and Accelerator Programs (GAP) Insights

What Happened Auburn University has received a $6 million, four-year award from the National Science Foundation’s Accelerating Research Translation (ART) program to strengthen its ability to move research discoveries into products, startups, industry partnerships, and technology licensing. The initiative will support faculty training, early-stage technology development, prototype creation, customer discovery,

What Happened Baylor College of Medicine has announced the public launch of BCM Legacy Fund I, LP, an early-stage biomedical venture fund designed to deploy philanthropic capital into promising startups emerging from academic research. The fund addresses a persistent financing challenge in biomedical commercialization. Universities generate discoveries with significant therapeutic

Research institutions have made meaningful investments in Gap Fund and Accelerator Programs (GAP) to advance technologies, support entrepreneurs, attract investment, and accelerate research commercialization. As these programs become more connected within broader GAP systems, we have an opportunity to better understand and communicate the full value they create. This is

Award & Investment Overview Ann Arbor-based Blue Arbor Technologies has closed a $10.5 million Series A financing round, led by strategic partner Ottobock, a global prosthetics and wearable bionics company. The investment will support continued development and clinical evaluation of Blue Arbor’s RESTORE Neuromuscular Interface System, designed to improve how

Award & Investment Overview Cornell University has awarded $292,869 to six research teams through the spring 2026 cycle of its Ignite Innovation Acceleration program. Managed by Cornell’s Center for Technology Licensing (CTL), the program provides milestone-driven GAP funding to advance university technologies toward licensing, startup formation, and industry partnerships. Each

Award & Investment Overview The University of Colorado has awarded a combined $1.6 million in commercialization grants to 12 research teams through its 2026 Lab Venture Challenge (LVC), supporting the development of university-originated technologies across biosciences, physical sciences, and engineering. Organized by Venture Partners at CU Boulder, the competition brings

Award & Investment Overview Illumion, a University of Cambridge spinout developing advanced optical imaging technology for battery research and development, has secured £1.7 million in financing with participation from ZEISS Ventures, the corporate venture capital arm of ZEISS Group. The funding round also included Foresight Group, Cambridge Enterprise Ventures, Parkwalk,

Representatives from over 40 research institutions gathered at The Ohio State University for COVERGENCE 2026 to examine one of the key challenges in research commercialization: helping promising discoveries reach the marketplace.  “My hope individually is that everyone here can bring something of value back to their institution,” said Jacob Johnson,